A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-union

Sponsor
University Hospital, Ghent (Other)
Overall Status
Terminated
CT.gov ID
NCT00551941
Collaborator
(none)
2
2
2
57.3
1
0

Study Details

Study Description

Brief Summary

The researchers propose a prospective, randomised partially-blinded study to investigate the clinical and radiological outcome, effect on quality of life and socio-economic impact of non-union of diaphysary tibial fractures treated with BMP-7 in adjunct to fresh frozen allograft, in comparison to treatment with allograft together with DBM (demineralised bone matrix).

Condition or Disease Intervention/Treatment Phase
  • Procedure: BMP-7 in adjunct to fresh frozen allograft
  • Procedure: allograft together with DBM
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
2 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomised Controlled Trial on the Use of BMP-7 (OP-1®) and Demineralised Bone Matrix in Tibial Non-union
Actual Study Start Date :
Oct 1, 2007
Actual Primary Completion Date :
Jul 9, 2012
Actual Study Completion Date :
Jul 9, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 2

non-union of diaphysary tibial fractures will be treated with allograft together with DBM

Procedure: allograft together with DBM
non-union of diaphysary tibial fractures treated with allograft together with DBM

Experimental: 1

non-union of diaphysary tibial fractures will be treated with BMP-7 in adjunct to fresh frozen allograft

Procedure: BMP-7 in adjunct to fresh frozen allograft
non-union of diaphysary tibial fractures treated with BMP-7 in adjunct to fresh frozen allograft

Outcome Measures

Primary Outcome Measures

  1. X-ray evaluation [After 9 months]

  2. Change in VAS and LEFS scores [After 9 months]

Secondary Outcome Measures

  1. Time of incapacity to work [Until ability to work]

  2. Change in SF-36 [After 4 years]

  3. Total socio-economic cost estimation [After 4 years]

  4. Repeated surgery (minor and major) [After 4 years]

  5. (Surgical) complications [After 4 years]

  6. Ability to bear weight (% of body weight) [After 4 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diaphysary tibial non-unions will be included (9 months after first surgery)

  • Major surgery includes exchange nailing, bone grafting, internal fixation, amputation and soft-tissue coverage procedures, such as delayed primary closure and free flaps

  • Surgery is classified as minor for removal of external fixator pins for local infection and removal of a static locking screw from intramedullary nails, a procedure known as dynamization

  • ASA 1 and ASA 2

  • Gap length/bone contact detected (1-5 cm): largest cortical gap in any radiographic incidence

  • Subject or legal guardian is willing and able to understand, sign and date the study specific Patient Informed Consent, which has been approved by the Institutional Review Board

  • Agrees to participate in post-operative evaluations and required rehabilitation regimen

Exclusion Criteria:
  • Patients with known hypersensitivity to the active substance or collagen

  • Gap more than 5 cm

  • Immature skeleton

  • Known auto-immune disease, including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, Sjögren's syndrome and dermatomyositis/polymyositis

  • Active infection on unhealed site or active systemic infection

  • Non-healing resulting from pathological fractures, tumours or metabolic bone diseases

  • Presence of tumour in vicinity of non-union

  • Patients receiving chemotherapy, radiotherapy or immunosuppressant treatment or excessive steroids

  • Patients with severely compromised soft tissue coverage or vascularisation at the non-union site, sufficient to impair bone healing

  • Patients with congenital non-union

  • Pregnancy and lactation

  • Non-union of multiple bones interfering with walking

  • Patients with neuromuscular diseases or conditions interfering normal weight bearing

  • Patients who, judged by the surgeon, are candidates for just internal fixation alone

Contacts and Locations

Locations

Site City State Country Postal Code
1 AZ Sint Jan-Brugge Brugge Belgium
2 University Hospital Ghent Ghent Belgium 9000

Sponsors and Collaborators

  • University Hospital, Ghent

Investigators

  • Principal Investigator: Rene Verdonk, MD, PhD, University Hospital, Ghent

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00551941
Other Study ID Numbers:
  • 2007/341
First Posted:
Nov 1, 2007
Last Update Posted:
Jul 8, 2021
Last Verified:
Jul 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2021